Alligo AB Series B (ALLIGO-B) - Total Liabilities

Latest as of March 2026: Skr5.91 Billion SEK ≈ $635.47 Million USD

Based on the latest financial reports, Alligo AB Series B (ALLIGO-B) has total liabilities worth Skr5.91 Billion SEK (≈ $635.47 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Alligo AB Series B - Total Liabilities Trend (2013–2025)

This chart illustrates how Alligo AB Series B's total liabilities have evolved over time, based on quarterly financial data. See Alligo AB Series B current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Alligo AB Series B Competitors by Total Liabilities

The table below lists competitors of Alligo AB Series B ranked by their total liabilities.

Company	Country	Total Liabilities
Yan Tai Shuang Ta Food Co Ltd SHE:002481	China	CN¥2.29 Billion
Shanxi Zhendong Pharmaceutical SHE:300158	China	CN¥882.65 Million
Wuhan Xingtu Xinke Electronics Co Ltd SHG:688081	China	CN¥164.84 Million
ShenZhen Zero-Seven Co Ltd SHE:000007	China	CN¥173.46 Million
Esperion Therapeutics Inc NASDAQ:ESPR	USA	$815.38 Million
Maravai Lifesciences Holdings Inc NASDAQ:MRVI	USA	$417.33 Million
EZTEC Empreendimentos e Participações S.A SA:EZTC3	Brazil	R$1.79 Billion
V V Food & Beverage Co Ltd SHG:600300	China	CN¥1.11 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Alligo AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Alligo AB Series B.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.04	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.53	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alligo AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alligo AB Series B (2013–2025)

The table below shows the annual total liabilities of Alligo AB Series B from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr5.86 Billion ≈ $630.74 Million	-0.95%
2024-12-31	Skr5.92 Billion ≈ $636.76 Million	+14.94%
2023-12-31	Skr5.15 Billion ≈ $554.01 Million	+3.98%
2022-12-31	Skr4.95 Billion ≈ $532.81 Million	-5.35%
2021-12-31	Skr5.23 Billion ≈ $562.94 Million	+9.87%
2020-12-31	Skr4.76 Billion ≈ $512.36 Million	+56.00%
2019-12-31	Skr3.05 Billion ≈ $328.44 Million	+91.11%
2018-12-31	Skr1.60 Billion ≈ $171.86 Million	+2.11%
2017-12-31	Skr1.56 Billion ≈ $168.31 Million	+1.30%
2016-12-31	Skr1.54 Billion ≈ $166.16 Million	-12.02%
2015-12-31	Skr1.75 Billion ≈ $188.87 Million	+0.46%
2014-12-31	Skr1.75 Billion ≈ $188.01 Million	-3.80%
2013-12-31	Skr1.82 Billion ≈ $195.43 Million	--

About Alligo AB Series B

ST:ALLIGO-B Sweden Industrial Distribution

Market Cap

$726.98 Million

Skr6.76 Billion SEK

Market Cap Rank

#10579 Global

#165 in Sweden

Share Price

Skr136.40

Change (1 day)

+1.04%

52-Week Range

Skr102.00 - Skr147.80

All Time High

Skr158.08